Integer Holdings Corp (ITGR) Stock
Fundamentals
Compare with ITGR
Recent news

GMED vs. ITGR: Which Stock Is the Better Value Option?
GMED vs. ITGR: Which Stock Is the Better Value Option?
ITGR

Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
ITGR

Integer Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Integer Holdings Corporation - ITGR
Integer Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Integer Holdings Corporation - ITGR
ITGR

SHAREHOLDER ALERT: Kaskela Law Announces Probe into $127.00 Per Share Buyout Offer – Fair or Inadequately Low Price for Integer (ITGR) Shares?
SHAREHOLDER ALERT: Kaskela Law Announces Probe into $127.00 Per Share Buyout Offer – Fair or Inadequately Low Price for Integer (ITGR) Shares?
ITGR
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 74.38
- MACD 12/26/9
- 1.00
- EMA 9 of MACD
- 1.36
- MACD histogram
- -0.36
- SMA 50
- $124.11
- Price above SMA 50
- EMA 50
- $121.02
- Price above EMA 50
- SMA 200
- $96.63
- Price above SMA 200
- EMA 200
- $100.63
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 6, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 6 analysts
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $1.53 for this quarter. The company has not yet shared when it is announcing earnings.
Latest news

GMED vs. ITGR: Which Stock Is the Better Value Option?
GMED vs. ITGR: Which Stock Is the Better Value Option?
ITGR

Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
ITGR

Integer Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Integer Holdings Corporation - ITGR
Integer Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Integer Holdings Corporation - ITGR
ITGR

SHAREHOLDER ALERT: Kaskela Law Announces Probe into $127.00 Per Share Buyout Offer – Fair or Inadequately Low Price for Integer (ITGR) Shares?
SHAREHOLDER ALERT: Kaskela Law Announces Probe into $127.00 Per Share Buyout Offer – Fair or Inadequately Low Price for Integer (ITGR) Shares?
ITGR

GMED vs. ITGR: Which Stock Should Value Investors Buy Now?
GMED vs. ITGR: Which Stock Should Value Investors Buy Now?
ITGR

ITGR Stock Alert: Halper Sadeh LLC is Investigating Whether Integer Holdings Corporation is Obtaining a Fair Price for its Shareholders
ITGR Stock Alert: Halper Sadeh LLC is Investigating Whether Integer Holdings Corporation is Obtaining a Fair Price for its Shareholders
ITGR

How Could KKR's $5.7 Billion Buyout Reshape ITGR for Shareholders?
How Could KKR's $5.7 Billion Buyout Reshape ITGR for Shareholders?
ITGR

Integer Holdings Corporation Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ITGR
Integer Holdings Corporation Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ITGR
ITGR

GMED or ITGR: Which Is the Better Value Stock Right Now?
GMED or ITGR: Which Is the Better Value Stock Right Now?
ITGR

ITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law
ITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law
ITGR
News tone: automated (AI) classification of the article's content, not a price prediction.
About Integer Holdings Corp
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Payman Khales | CEO, President & Director | 1970 |
| Mr. Diron Smith | Executive VP & CFO | 1973 |
| Ms. Lindsay Krause Blackwood J.D. | Senior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary | 1977 |
| Mr. Andrew Senn | President of Growth & Innovation | 1982 |
| Mr. Jim Stephens | Executive Vice President of Special Projects | 1974 |
| Mr. Tom P. Thomas | VP, Corporate Controller & Principal Accounting Officer | 1971 |
| Ms. Carol Russell | VP & Chief Information Officer | — |
| Ms. Kristen Marie Stewart C.F.A. | Director of Investor Relations | — |
| Mr. Kirk K. Thor Ph.D. | Executive VP & Chief Human Resources Officer | 1964 |
| Mr. John Harris | President of Global Operations & Manufacturing Technology | 1960 |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Technical indicators
- RSI 14
- 74.38
- MACD 12/26/9
- 1.00
- EMA 9 of MACD
- 1.36
- MACD histogram
- -0.36
- SMA 50
- $124.11
- Price above SMA 50
- EMA 50
- $121.02
- Price above EMA 50
- SMA 200
- $96.63
- Price above SMA 200
- EMA 200
- $100.63
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 6, 2026. Technical data, not a recommendation.
Analyst views
7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $96.00
- Average
- $116.67
- High
- $127.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +0.6 | -10.0 | +7.3 | |||||||||
| 2022 | -7.7 | +6.0 | -0.3 | -8.9 | +4.9 | -9.4 | -2.9 | -10.0 | -0.1 | -2.1 | +16.3 | -7.6 |
| 2023 | -3.9 | +8.7 | +1.3 | +9.2 | -1.1 | +7.2 | +4.5 | -7.9 | -7.7 | +4.0 | +5.8 | +11.8 |
| 2024 | +3.1 | +6.2 | +4.6 | -3.8 | +10.4 | -4.6 | +3.1 | +12.0 | +2.5 | -2.3 | +11.1 | -4.5 |
| 2025 | +7.6 | -10.9 | -1.8 | +6.5 | -5.4 | +4.5 | -10.5 | +1.3 | -3.4 | -37.3 | +7.8 | +9.3 |
| 2026 | +13.1 | +1.3 | +1.9 | +2.4 | +6.4 | +3.6 | +28.2 | +0.6 | +0.8 | +0.0 |




